As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...
DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
If you are wondering whether DexCom stock still offers value after a choppy few years, this article walks through what the ...
On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The Food and Drug Administration cleared Dexcom’s Stelo Glucose Biosensor ...
DexCom develops and markets continuous glucose monitoring (CGM) systems, a type of device that continuously tracks blood sugar levels. The technology isn't exactly new anymore, and it has enjoyed ...
Users can go to dexcom.com/theft-check for information on how to determine if sensors are from the affected lots and what ...
Insulet (PODD) stock and DexCom (DXCM) receive new Buy ratings from Deutsche Bank while Tandem Diabetes Care (TNDM) stock ...
Mark Andrews may be one of the best tight ends in the NFL, but he has not forgotten about the kids playing college football ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results